Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 11:10 am EDT
Share
Changjiang Runfa Health Industry Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 905.41 million compared to CNY 1,045.97 million a year ago. Revenue was CNY 905.41 million compared to CNY 1,045.97 million a year ago. Net income was CNY 62.12 million compared to CNY 88.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.0503 compared to CNY 0.0713 a year ago. Diluted earnings per share from continuing operations was CNY 0.0503 compared to CNY 0.0713 a year ago.
ChangjiangRunfa Health Industry Co., Ltd., formerly ChangjiangRunfa Medicine Co., Ltd., is a China-based company mainly engaged in the production and sale of pharmaceutical raw materials and preparations. The Company is principally engaged in research and development, production and sales of pharmaceutical raw materials and preparations, proprietary Chinese medicines and providing medical services, medical investment and investment in health industry businesses. The Company is also engaged in the research, development, manufacture, sale and service of elevator guide rail system components. The Companyâs products include solid guide rails, rough guide rails, hollow guide rails, accessories and automotive sections, channel steel products, as well as escalator guide rails and others. The Company offers its elevator guide rail products for elevator manufacturers, including Mitsubishi, Otis, KONE and Thyssen. The Company distributes its products in domestic markets and to overseas markets.